Navigation Links
Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
Date:12/1/2008

COLUMBIA, S.C., Dec. 1 /PRNewswire/ -- Welvista is pleased to announce it has reached an agreement with sanofi-aventis U.S., one of the world's leading pharmaceutical companies, to dispense the company's medications to the uninsured through Welvista's no-cost prescription medication program. With the addition of 23 sanofi-aventis drugs from the company's Patient Assistance Programs (PAPs), Welvista now has 180 drugs on its formulary for the uninsured. Including sanofi-aventis, Welvista now partners with 12 pharmaceutical companies, making it the largest mail-order pharmacy for the uninsured in the country.

Welvista provides an innovative prescription drug program for residents in three states who fall below 200 percent of the federal poverty level and are without health insurance coverage. The William E. Murray pharmacy, located at Welvista's headquarters off Forest Drive in Columbia, dispensed more than $34 million dollars in prescription medications in 2007 to Welvista's patients to treat diabetes, hypertension, mental illness and more.

Welvista also provides oral healthcare services for the children of limited income families in South Carolina through Smiles for a Lifetime, with centers in Allendale County, Dillon II, Clarendon I and II school districts, and Charleston.

"Our pharmaceutical partners are essential to the success of our organization; we wouldn't exist without them," says Welvista CEO Ken Trogdon. "We are committed to improving health and wellness for the uninsured. Our model has proven its viability, and we will continue to add prescription drugs that we know our patients need."

About Welvista

Welvista is an innovative model of non-governmental healthcare intervention serving thousands of patients in three states. This healthcare network provides medications at no cost to the uninsured who do not qualify for Medicaid, Medicare or VA insurance and for those who cannot afford to pay for insurance coverage on their own. Welvista also operates Smiles, five pediatric dental care centers caring for approximately 5,000 children from limited income families who would not otherwise have access to oral healthcare. With the addition of sanofi-aventis U.S., Welvista now partners with 12 pharmaceutical companies that donate prescription drugs to approved patients. To learn more about the organization, visit www.welvista.org.

About sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT:SAN) and in New York (NYSE: SNY). For more information, visit: www.sanofi-aventis.us or www.Sanofi-aventis.com.


'/>"/>
SOURCE Welvista
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Based on research from Guardian’s ... face in trying to balance both short-term and long-term benefits demands. Are ... the growing complexity, companies are finding that the short-term strategies used to control ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... ... 29, 2017 , ... AvePoint , the Microsoft Cloud expert, is pleased ... Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with ... S. Northam and Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017 Varian Medical Systems (NYSE: ... for the second quarter of fiscal year 2017 following the ... news release will be followed by a teleconference available to ... and a link to the conference call webcast will be ... access the teleconference call and replay: ...
(Date:3/29/2017)... , March 29, 2017   Royal Philips ... in health technology, and PathAI, a company that ... with the aim to develop solutions that improve ... cancer and other diseases. The partnership aims to ... this form of artificial intelligence to be applied ...
(Date:3/29/2017)... TEL AVIV, Israel , March 29, 2017 ... license agreement in which Exeltis will obtain exclusive marketing rights for ... ... is an age-appropriate drug targeted to treat sleep disorders in children ... to be the first sleep medication approved for children. ...
Breaking Medicine Technology: